Correction to: Leukemia
This article was originally published under NPG’s License to Publish, but has now been made available under a CCBY license. The PDF and HTML versions of the paper have been modified accordingly.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/leu.2017.346.
Rights and permissions
About this article
Cite this article
Tirado-Gonzalez, I., Czlonka, E., Nevmerzhitskaya, A. et al. Correction: CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. Leukemia 35, 294 (2021). https://doi.org/10.1038/s41375-020-01071-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-020-01071-7
This article is cited by
-
CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
Molecular Biology Reports (2022)
